NFATC2 and Burkitt lymphoma: Antigen receptor-driven apoptosis of transformed B cells (Burkitt lymphoma) also has been shown to be a consequence of Nfatc2-mediated signals [43], suggesting loss of Nfatc2 could provide a survival advantage to malignant B cells.